The amount of the ERA PerMed grant for the University of Helsinki is 450 000 euros. At the University of Helsinki, the consortium is led by Academy Research Fellow Markku Varjosalo, Institute of Biotechnology, HiLIFE. The project is called TIPS (Tailored Immunotherapy for Paediatric SIRS). Diagnostic tools to guide targeted treatmentThe systemic inflammatory response syndrome (SIRS) mimics or is caused by infectious sepsis. “Investigation of root causes, tailored treatments and prognosis of severe paediatric SIRS may improve if collective characterization and quantification omics are utilized,” Markku Varjosalo says.
